Are TKIs favourable for the elderly with non-small-cell lung cancer?

BACKGROUND: Epidermal Growth Factor Receptor (EGFR) tyrosine-kinase inhibitors (TKIs) have changed treatment strategies for patients with advanced non-small-cell lung cancer (NSCLC) harbouring mutations in EGFR gene. This retrospective analysis assessed efficacy and safety of TKIs in elderly compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Sabrina, D'Argento, Ettore, Schinzari, Giovanni, Dadduzio, Vincenzo, Di Noia, Vincenzo, Cassano, Alessandra, Barone, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper: Gerotarget (Focus on Aging)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216909/
https://www.ncbi.nlm.nih.gov/pubmed/27206674
http://dx.doi.org/10.18632/oncotarget.9389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216909/
https://www.ncbi.nlm.nih.gov/pubmed/27206674
http://dx.doi.org/10.18632/oncotarget.9389

Ejemplares similares